Biotech Values

[DewDiligence]

Take off your rose color glasses and stop talking your book and start acting impartial.

There you go again, trying to change this into a thread about me rather than a thread about IDIX. Sadly, this has become your regular MO on this board.

To recap: NVS’ decision on IDX184 was not good news for IDIX, but it was not horrible news either. NVS’ decision does not imply that IDX184 is unpartnerable, which is what you asserted in your prior post. I cited IDX899 as proof that your analysis is erroneous.

I’m done with this thread. Have the last word if you want it.